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Expression of the GLUT4 (glucose transporter type 4 isoform)
gene in adipocytes is subject to hormonal or metabolic control. In
the present study, we have characterized an adipose tissue tran-
scription factor that is influenced by fasting/refeeding regimens
and insulin. Northern blotting showed that refeeding increased
GLUT4 mRNA levels for 24 h in adipose tissue. Consistent
with an increased GLUT4 gene expression, the mRNA levels of
SREBP (sterol-regulatory-element-binding protein)-1c in adipose
tissue were also increased by refeeding. In streptozotocin-induced
diabetic rats, insulin treatment increased the mRNA levels of
GLUT4 in adipose tissue. Serial deletion, luciferase reporter
assays and electrophoretic mobility-shift assay studies indicated
that the putative sterol response element is located in the region
between bases −109 and −100 of the human GLUT4 promoter.
Transduction of the SREBP-1c dominant negative form to differ-
entiated 3T3-L1 adipocytes caused a reduction in the mRNA
levels of GLUT4, suggesting that SREBP-1c mediates the tran-
scription of GLUT4. In vivo chromatin immunoprecipitation
revealed that refeeding increased the binding of SREBP-1 to
the putative sterol-response element in the GLUT4. Furthermore,
treating streptozotocin-induced diabetic rats with insulin restored
SREBP-1 binding. In addition, we have identified an Sp1 binding
site adjacent to the functional sterol-response element in the
GLUT4 promoter. The Sp1 site appears to play an additive role
in SREBP-1c mediated GLUT4 gene upregulation. These results
suggest that upregulation of GLUT4 gene transcription might be
directly mediated by SREBP-1c in adipose tissue.
Key words: adipocytes, insulin, sterol-response element, sterol-
regulatory-element-binding protein-1c (SREBP-1c), type 4 glu-
cose transporter isoform (GLUT4).
INTRODUCTION
GLUT4 (the glucose transporter type 4 isoform) is a member of
the glucose transporter family that is mainly expressed in skeletal
muscle, heart and adipose tissues. GLUT4 plays a critical role in
insulin-stimulated glucose transport in these tissues, with glucose
uptake occurring when insulin stimulates the translocation of
GLUT4 from the intracellular pool to the plasma membrane [1].
Additionally, the intrinsic activity of GLUT4 can also be regulated
by covalent modification [2].
T2DM (type 2 diabetes mellitus) is characterized by defects
in both insulin action and insulin secretion [3]. Central to this
pathology is insulin resistance, manifested by decreased glucose
disposal in response to insulin [4,5]. Studies have reported that
T2DM patients display a marked decrease in insulin-stimu-
lated glucose disposal in muscle [6]. One of the mechanisms
underlying this defect involves defects in insulin signalling path-
way components, including phosphatidylinositol 3-kinase [7],
insulin receptor substrate-1 [8,9] and Akt kinase [9–11]. In this
diabetic condition, overexpression of the GLUT4 gene in muscle
or adipose tissue enhances insulin responsiveness and peripheral
glucose utilization [12]. Moreover, transgenic db/db mice over-
expressing the GLUT4 gene showed improved insulin resist-
ance [13]. Regulation of the level of GLUT4 protein is accom-
plished by increased biosynthesis, decreased degradation or both
[14,15]. However the molecular mechanisms that govern regu-
lation of GLUT4 gene expression remain largely unknown.
GLUT4 gene expression is known to be regulated by various
physiological conditions. In obese or T2DM human subjects
[16,17], GLUT4 gene expression is decreased due to the com-
pensatory hyperinsulinaemia that occurs in these patients [18].
In addition, insulin treatment of 3T3-L1 adipocytes results in
a rapid (within 4 h) decrease in GLUT4 mRNA levels [19],
suggesting that insulin acts as a negative regulator of GLUT4.
In contrast, GLUT4 gene expression is down-regulated in STZ-
(streptozotocin)-induced diabetes and chronic fasting, a state of
relative insulin deficiency, suggesting that insulin acts as a posi-
tive regulator of GLUT4 gene expression [20]. Some studies indi-
cate that during insulin deficiency states, increased intracellular
cAMP levels or other transcription factors signal the repression
of GLUT4 gene expression [21,22].
ADD1/SREBP-1c (adipocyte determination and differentiation
dependent factor 1/sterol-regulatory-element-binding protein-1c)
is a trans-acting factor that regulates transcription of genes
involved in cholesterol and fatty acid synthesis [23–26] and is
abundantly expressed in the liver and adipose tissue [27]. In
the liver, SREBP-1c has a well documented role as an insulin-
mediated transcriptional activator of genes involved in carbo-
hydrate and lipid metabolism [28,29]. Despite the established
role of SREBP-1c in the liver, the influence of SREBP-1c on
GLUT4 and other genes involved in carbohydrate metabolism in
adipocytes is not clear.
In the present study, we identified the SRE (sterol-reponse
element) in the promoter region of GLUT4. We also demonstrated
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that SREBP-1c directly mediates the upregulation of GLUT4 in
the adipose tissues of the fasting/refeeding cycle or in STZ-treated
rats that have been treated with insulin.
EXPERIMENTAL
Animals, diet and the induction of diabetes by STZ
Male Sprague–Dawley rats (weighing approx. 200 g each) were
fasted for 48 h and then fed a fat-free, high carbohydrate diet for
the indicated period. The fat-free, high carbohydrate diet con-
tained 82% (w/w) carbohydrates (74% starch and 8% sucrose),
18% (w/w) casein, 1% vitamin mix and 4% (w/w) mineral
mix. Animals had free access to water at all times. All the
materials for the diet were purchased from Harlem Teklad Co.
(Madison, WI, U.S.A.). Diabetes was induced in the rats by
a single intravenous injection of 0.5 ml 50 mM sodium citrate
solution (pH 4.5) containing STZ (50 mg/kg body weight, Sigma).
Control rats were injected with 50 mM sodium citrate solution
(pH 4.5). The induction of diabetes was monitored by measuring
blood glucose level (>300 mg/dl). The animals were then fed a
chow diet for 12 h, after which insulin was administered to the
STZ + insulin group. The animals received 0.5 mM/kg insulin
(Sigma, Cat. I-9278) intraperitoneally. The control STZ group rats
were injected with the same volume of PBS. After the injection
of insulin or PBS, the animals were fed a chow diet for 6 h and
then killed by halothane anaesthesia.
Cell culture
3T3-L1 preadipocytes (ATCC number CL-173) were cultured
in DMEM (Dulbecco’s modified Eagle’s medium) and supple-
mented with 10% (v/v) FCS (fetal calf serum), 100 units/ml
penicillin and 100 µg/ml streptomycin. 3T3-L1 preadipocytes
were differentiated into adipocytes as described previously [30].
Nuclear lysate preparation and Western blot for mature
SREBP-1c detection
Rat epididymal adipose tissues were homogenized for 15–
30 sec using a Polytron homogenizer (Wheaton) in 1.5 ml homo-
genization buffer [20 mM Tris/HCl (pH 7.4), 2 mM MgCl2,
0.25 M sucrose, 10 mM EDTA, 10 mM EGTA, proteases (1 M
dithiothreitol and 0.1 M PMSF) and 1× protease inhibitor cocktail
(5 mM leupeptin, 5 mM pepstatin, 5 mM chymostatin and 5 mM
aprotinin)]. The homogenates were kept on ice for 10 min and
spun down for 5 min at 2500 g in an Eppendorf 5810R tabletop
centrifuge at 4 ◦C. The pellet was resuspended in 1 ml homo-
genization buffer including protease inhibitor cocktail and nuclei
were spun down at 1000 g for 5 min at 4 ◦C. The pellet was
resuspended with 300 µl buffer C [20 mM Hepes (pH 7.6), 2.5%
glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA and protease inhibitor cocktail]. Western blot analysis
was performed as described previously [31]. Seventy micro-
grams of nuclear lysate was prepared by adding 1× SDS sample
loading buffer followed by 20 bursts of sonication (Cycle, 0.5;
amplitude 80%) and boiling at 95 ◦C for 5 min. The protein
samples were separated by SDS/PAGE (10% gel) and trans-
ferred to nitrocellulose membranes (Schleicher & Schuell Bio-
Science GmbH). The blotted membranes were immunostained
with antibodies for SREBP-1 (1:2000) which was prepared as
described previously [25] and α-tubulin (1:4000; Calbiochem,
Darmstadt, Germany) and subsequently detected by ECL®
(Amersham Biosciences).
Isolation of total RNA and Northern blot analysis
Total cellular RNAs were extracted from the epididymal WAT
(white adipose tissue) of Sprague–Dawley rats using TRIzol®
reagent (Invitrogen) and were prepared according to the manu-
facturer’s protocol. Labelling of each cDNA probe (SREBP-
1c and GLUT4) with [α-32P]dCTP was performed using the
Rediprime labelling kit (Amersham Biosciences).
Construction of human GLUT4 promoter–luciferase plasmids
The human GLUT4 promoter fragments spanning −2031/+61
were subcloned into the KpnI and XhoI sites of the pGLM
plasmid which was mutated to the E-box upstream of the mul-
tiple cloning site of the pGL3 basic vector (Promega) in order
to abolish the effect of SREBP-1c. Serial deletions from the 5′
end of human GLUT4 promoter reporter constructs, pHGT4-
828, pHGT4-313, pHGT4-119, pHGT4-92, and pHGT4-41 were
formed by amplifying the regions of −828/+61, −313/+61,
−119/+61, −92/+61 and −41/+61 respectively, and these
were subcloned into the pGLM basic vector. The SRE-trun-
cated promoter reporter pHGT4t-133/−36 was constructed from
pHGT4d-313 using an SRE-truncated primer (sense: 5′-CCAA-
ACTCTAAACGCTTCTCGCGTCTTTTCCC-3′, anti-sense: 5′-
GACGCGAGAAGCCGTTTAGAGTTTGGCTGGAGT-3′). Mu-
tant constructs pHGT4-Sp1m (Ma), pHGT4-SREm (Mb), and
pHGT4-Sp1m/SREm (Mab) were generated from pHGT4d-313
with the mutagenic oligonucleotides (30 mer, see Figure 5A) using
Pfu polymerase (Stratagene). The sequences of all constructs were
confirmed using the T7 sequencing kit (Amersham Biosciences).
All transfection plasmids were prepared with the Plasmid Midi
Kit (Qiagen).
Transient transfection assay
3T3-L1 preadipocytes were plated at a density of 2 × 105 cells/
35 mm dish. On the following day, transfection was performed
with 0.5 µg of the indicated GLUT4 promoter–luciferase con-
structs, 0.1 µg of pCMV-β-galactosidase plasmid (Clontech), the
indicated amounts of pcDNA3, pCMV7-SREBP-1c and ADDN
(the dominant negative mutant of SREBP-1c) expression plasmids
[32]. Transient transfections were performed using Lipofectamine
Plus reagent (Life Technologies) for 3 h according to the
manufacturer’s instructions. After two days, cells were washed
with PBS and lysed in 150 µl of reporter lysis buffer (Promega).
Luciferase activities were measured using the Luciferase Assay
System (Promega) and normalized with 20 µg of protein, as
measured by the Bradford assay [33].
Electrophoretic mobility-shift assay (EMSA)
Probes for the gel shift assays were labelled with [γ -32P]ATP
and T4 polynucleotide kinase. Labelled double-stranded oligo-
nucleotides were prepared by mixing a 5-fold molar excess of
the complementary single-stranded DNA in 50 mM NaCl which
was heated to 90 ◦C for 5 min and cooled to room temperature
(25 ◦C). Recombinant SREBP-1 and antiserum against SREBP-1
were prepared as described previously [25]. The recombinant
Sp1 zinc finger DNA binding domain was prepared as described
previously [34]. The labelled probe (50000 cpm) and purified
SREBP-1 and Sp1 [in 25 mM Tris/HCl (pH 7.4), 80 mM KCl,
0.1 mM EDTA, 1 mM dithiothreitol and 10% (v/v) glycerol]
were incubated for 30 min on ice and resolved on a non-denatured
4% acrylamide gel [acrylamide/bisacrylamide, 29:1 (w/w)] in
1× TBE [45 mM Tris borate, 0.1 mM EDTA (pH 8.0)] at
4 ◦C. A competition experiment was performed using a molar
excess of unlabelled oligonucleotide including the SRE region
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Table 1 Sequence of oligonucleotides used for the EMSA
Mutated bases are represented in bold and underlined.
Oligonucleotide Sequence (5′→3′)
SREa sense GAGGGGGCGTGGCCTTCTGGGGTGTGCGGGCTCCTGGCCAATGGGTGC
antisense GCACCCATTGGCCAGGAGCCCGCACACCCCAGAAGGCCACGCCCCCTC
SREb sense GAGGGGTTTTGGCCTTCTGGGGTGTGCGGGCTCCTGGCCAATGGGTGC
antisense GCACCCATTGGCCAGGAGCCCGCACACCCCAGAAGGCCAAAACCCCTC
SREc sense GAGGGGGCGTGGCCTTCAAGGGAATGCGGGCTCCTGGCCAATGGGTGC
antisense GCACCCATTGGCCAGGAGCCCGCATTCCCTTGAAGGCCACGCCCCCTC
LDLR sense TTGAAAATCACCCCATTGCAGACTCCTCCCCGGC
antisense GCCGGGGAGGAGTCTGCAATGGGGTGATTTTCAA
in the low-density lipoprotein receptor (LDLR) promoter [35].
The non-specific competitor, 1.5 µg of poly(dI-dC), was added
to each binding reaction. The dried gels were exposed to X-ray
film at −70 ◦C with an intensifying screen. The oligonucleotide
sequences used for the EMSA are summarized in Table 1. Mutated
bases are represented in bold and are underlined.
Adenovirus preparation and infection
Recombinant GFP (green fluorescent protein), full-length
SREBP-1c and ADDN adenoviruses were generated as described
previously [29]. Differentiated 3T3-L1 adipocytes were treated
with 100 nM insulin and transduced with 5 ml of adenovirus-
containing DMEM at the indicated MOI (multiplicity of infection)
for 16 h at 37 ◦C. The culture medium was then adjusted to 10 ml
with DMEM supplemented with 10% FCS. After incubation for
a total of 48 h, cells were harvested and RNA was isolated using
TRIzol® reagent (Invitrogen) according to the manufacturer’s
protocol.
Real-time PCR
Total RNA was isolated from differentiated 3T3-L1 adipocytes
using TRIzol® reagent. For reverse transcription, cDNA was
prepared as described previously [36]. Primers for GLUT4 and
α-tubulin were designed using MacVector software (Accelrys).
The PCR reaction mixture was processed as described previously
[36]. Briefly, we used 1 µl of the commercial, ready-to-use mix-
ture LightCycler-DNA Fast Start master hybridization probes
(Roche Diagnostics), 5 mM MgCl2 (final concentration) and pri-
mers and probes at final concentrations of 5 and 1 µM respect-
ively. Real-time PCR was performed using a LightCycler instru-
ment (Roche Diagnostics). The conditions for thermal cycling
were as follows: initial denaturation for 10 min, followed by 40
amplification cycles at 95 ◦C for 10 s, 55 ◦C for 5 s and 72 ◦C for
14 s. Fluorescence was measured at 640 nm (F2 channel) at the
end of each annealing phase. The amplification was followed by
a melting programme, which started at 45 ◦C for 15 s and then in-
creased to 95 ◦C at 0.1 ◦C/s with the fluorescence signal conti-
nuously monitored. The primers and probes used were: GLUT4
sense: 5′-AGAGTCTAAAGCGCCT-3′, antisense: 5′-CCGAGA-
CCAACGTGAA-3′, FAS (fatty acid synthase) sense: 5′-GA-
AGCTCGTGTTGACTTCTC-3′, antisense: 5′-AGAAGACCAC-
AAAGTAGTCCAG-3′, α-tubulin sense: 5′-CTCGCATCCACT-
TCCCT C-3′, antisense: 5′-ATGCCCTCACCCACGTAC-3′.
Reverse transcriptase (RT)-PCR
For RT-PCR, RNA was isolated from differentiated 3T3-L1
adipocytes using TRIzol® reagent. For reverse transcription,
cDNA was prepared as described previously [36]. RT-PCR was
performed as described previously [30]. The conditions for
thermal cycling were as follows: initial denaturation for 10 min,
followed by 25 amplification cycles at 95 ◦C for 30 s, 58 ◦C for
30 s and 72 ◦C for 30 s. The sequences used for RT-PCR were
as follows: FAS sense: 5′-GAAGCTCGTGTTGACTTCTC-3′,
antisense: 5′-AGAAGACCAC AAAGTAGTCCAG-3′, SCD1
(stearoyl CoA desaturase-1) sense: 5′-ATGCCGGCCCACA
TGCTCCA-3′, antisense: 5′-CATGAGGATGATGTTCCTCC-3′.
β-actin sense: 5′-TTGTAAC CAACTGGGACGATATGG-3′,
antisense: 5′-CGACCAGAGGC ATACAGGGACAAC-3′.
ChIP (chromatin immunoprecipitation) assay
The ChIP assay was performed following a modified protocol
based on a previously described method [37]. Briefly, rats were
killed and perfused with 100 ml of ice-cold PBS (pH 8.0) through
the left ventricle of the heart and fixed with 200 ml of 5%
formaldehyde in ice-cold PBS (pH 8.0). Again, the rats were
perfused with 100 ml of ice-cold PBS (pH 8.0) to wash out the
formaldehyde. Epididymal WAT was homogenized and sonicated.
The sonicated supernatant was divided into aliquots (100 µl) for
subsequent 10-fold dilution in ChIP dilution buffer [0.01% SDS,
1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris/HCl (pH 8.0)
and 167 mM NaCl] and precleared with 50% slurry of protein
A–agarose/salmon sperm DNA for 1 h. The antibody was added
and incubated overnight at 4 ◦C. The complexes were collected
with 50% slurry of protein A–agarose/salmon sperm DNA for
1 h. The beads were washed and chromatin complexes were
eluted from the beads. The DNA was purified after the cross-
linking was reversed and 3 µl of input control or ChIP samples
were used as templates for PCR. The primer sets for SRE were
used for the GLUT4 promoter. The GLUT4 promoter primers
were as follows: sense, 5′-CTTTTGTTCCAGGGACTCTTTT-3′;
antisense, 5′-CACAAGCCAAGGATCCGGAGAG-3′.
Statistical analysis
All of the transfection studies were performed in 3–5 separate
experiments, where triplicate dishes were transfected. The results
are presented as means +− S.D. Statistical analysis was performed
using Microsoft Excel. An unpaired t test with a P value of <0.05
was used to determine statistical significance.
RESULTS
Effect of insulin and refeeding on SREBP-1 and GLUT4 mRNA
levels in epididymal WAT
STZ treatment or 48 h fasting resulted in the decrease in GLUT4
mRNA levels in epididymal WAT. Insulin administration restored
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Figure 1 Effect of refeeding on SREBP-1 and GLUT4 mRNA levels in
epidydimal WAT
(A) GLUT4 mRNA levels. Diabetes was induced by administering STZ (50 mg/kg) to
Sprague–Dawley rats (approx. 200 g body weight) and the blood glucose concentration was
checked to confirm the onset of diabetes. Normal rats were subjected to fasting for 48 h. Insulin
(0.5 mM/kg) was administered to STZ-diabetic rats. (B) Time course measurements of GLUT4
mRNA levels. Rats were fasted for 48 h and refed a fat-free, high-carbohydrate diet ad libitum.
After refeeding, the rats were sacrificed at the time periods indicated. Total RNA (20 µg) isolated
from epididymal WAT was subjected to 0.9 % formaldehyde–agarose gel electrophoresis. The
RNA in the gel was transferred to a nylon membrane and hybridized to 32P-labeled cDNAs for
GLUT4, SREBP-1 or β-actin. Representative Northern blots are shown for GLUT4, SREBP-1 and
β-actin mRNA from normal (n = 3) or diabetic (n = 3) rats. (C) Kinetics of SCD1 and FAS mRNA
induction after refeeding. (D) Time course measurement of mature SREBP-1 protein expression
after refeeding. The mature form of SREBP-1 was measured by fractionating nuclear lysate from
adipose tissue as described in the Experimental section. The expression level of endogenous
GLUT4 gene (E) and FAS (F) induced by SREBP-1c adenovirus in 3T3-L1 adipocytes. After
infecting SREBP-1c adenovirus at 100 MOI for 48 h in differentiated 3T3-L1 adipocytes, GLUT4
and FAS gene expression was confirmed by real-time PCR. Values are mean +− S.E.M (n = 3).
P < 0.001 compared to mock group. Ad: ad libitum, Ins: insulin treated, NS: non-specific band.
GLUT4 mRNA levels in STZ-induced diabetic rats (Figure 1A),
suggesting that insulin promotes expression of the GLUT4 gene.
Because SREBP-1c is known to be one of the key mediators of
insulin action, we measured both SREBP-1c and GLUT4 mRNA
levels in the epididymal WAT of refed rats (Figure 1B). Time
course measurement of SREBP-1 mRNA levels in epididymal
WAT showed that mRNA levels increased after 6 h of refeeding.
SCD1 mRNA was induced after 6 h whereas FAS mRNA was
increased after 12 h by refeeding (Figure 1C). In the nuclear
fraction of WAT, mature SREBP-1c began to be increased after
refeeding for 6 h (Figure 1D). In the differentiated 3T3-L1
adipocytes, the expression level of the endogenous GLUT4 gene
was activated by overexpressed adenovirus expressing SREBP-1c
(Figure 1E). The FAS gene is known to be regulated by SREBP-
1c and was therefore used as a positive control. mRNA levels
of the FAS gene were also increased by exogenous SREBP-1c
(Figure 1F). These results suggest that GLUT4 expression may
be linked to SREBP-1 expression in adipose tissue.
Localization of SRE in the human GLUT4 promoter
A homology search of the consensus sequence between the
human and rat GLUT4 promoter regions suggested that highly
conserved Sp1 and SRE sites might be present in the region
between −125 bp and −77 bp (Figure 2A). To exclude the effect
of endogenous GLUT4 and SREBP-1c, 3T3-L1 preadipocytes
were used in the transient transfection assay. Promoter reporter
(pHGT4-2031) activity was increased by the ectopic expression
of SREBP-1c in 3T3-L1 preadipocytes (Figure 2B, ∗P < 0.001,
untransfected versus SREBP-1c group). The stimulatory effect of
SREBP-1c on the promoter reporter was suppressed by the co-
transfection of the ADDN with the SREBP-1c expression vector
(Figure 2B, #P < 0.05, SREBP-1c versus SREBP-1c + ADDN
group), indicating that SREBP-1c acts as an activating trans-
acting factor of the GLUT4 promoter.
To localize the putative SRE in the human GLUT4 promoter,
serial deletion constructs of the 5′-flanking region of the GLUT4
promoter (phGT4 − 2031/+66) were prepared and we analysed
their responsiveness to SREBP-1c in 3T3-L1 preadipocytes
(Figure 2C). The effect of SREBP-1c was decreased by deleting
the bases down to −92 bp, indicating that a putative SRE could
be located between the −119 bp and −92 bp regions (Figure 2C,
∗P < 0.005, pHGT4d-119 versus pHGT4d-92). Internal deletion
of the putative SRE region (pHGT4t-133/36) resulted in a loss of
responsiveness to SREBP-1c (Figure 2C).
Identification of an SRE and binding of SREBP-1c
in the GLUT4 promoter
EMSA was performed to identify the SRE in the −125 bp and
−79 bp region. Recombinant SREBP-1 [25] bound well to the
probe (−125 bp/−79 bp fragment) in a dose-dependent manner
up to a concentration of 80 ng (Figure 3). The protein–DNA
complex formation was abolished by adding 10-fold excess of
non-radioactive SRE from the LDLR promoter. The addition
of anti-SREBP-1 antibody caused a supershift of the SREBP-1
protein–DNA complex.
Binding of Sp1 and SREBP-1 to the GLUT4 promoter
Figure 4(A) shows the putative cis-elements, Sp1 and SREBP-1,
binding to the GLUT4 promoter. Combinations of cis-element
mutants were generated by site-directed mutagenesis in order
to confirm the identity of the cis-element. SREa, which contains
putative Sp1 and SRE binding sites binds both Sp1 and SREBP-1.
Binding of SREBP-1 to SREa was confirmed by supershift assay
(Figure 4B). The SREb probe, which carries a mutated Sp1
binding site, forms a protein–DNA complex when recombinant
SREBP-1 is added. SREb failed to bind Sp1 (Figure 4C).
Introduction of a mutation into the core sequence of SRE (Fig-
ure 4D) caused a loss of SREBP-1 binding. These data indicate
that the Sp1 and SRE binding sites are located at −122 bp/
−113 bp and −109 bp/−100 bp respectively.
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Figure 2 Localization of SRE in the human GLUT4 promoter
(A) Comparison of human and rat GLUT4 promoter sequences. (B) The effect of SREBP-1c
on GLUT4 promoter activity. pHGT4-2031 promoter reporter (500 ng) was cotransfected with
SREBP-1c (100 ng) or SREBP-1c plus ADDN into 3T3-L1 preadipocytes cell lines that were
plated at a density of 2 × 105 cells/35 mm dish. Transient transfection, luciferase assays and
measurement of total protein concentration of the lysates were performed as described in the
Experimental section. *P < 0.001, untreated versus SREBP-1; #P < 0.05, SREBP-1c versus
SREBP-1c + ADDN. (C) The effect of deletion on the SREBP-1c-mediated GLUT4 promoter
activity. Schematic diagram of serial deletion constructs of the GLUT4 promoter reporter (left)
and SREBP-1c mediated GLUT4 promoter activity (right). The indicated numbers represent the
number of nucleotides from the mRNA start codon. The promoter activities were measured by
co-transfecting 100ng of SREBP-1c expression or empty vectors into 3T3-L1 preadipocytes.
The results were normalized by the amount of total protein in the lysates, which was determined
by the Bradford method and shown as the fold changes of luciferase activities compared to
those of the control. Normalized luciferase activities are shown as the means +− S.D. of three
independent experiments in triplicate. *P < 0.005, pHGT4d-119 versus pHGT4d-92.
The functional role of Sp1 and SREBP-1 binding sites
in the GLUT4 promoter
To analyse the functional role of the Sp1 and SREBP-1c binding
sites on the activity of the GLUT4 promoter, we mutated
the core binding sites for the respective transcription factors
(Figure 5A). Figure 5(B) shows the effect of Sp1 and/or SREBP-
1c overexpression on GLUT4 promoter activity. As shown, the
ectopic expression of SREBP-1c strongly activated the GLUT4
promoter (∗P < 0.001, untransfected versus SREBP-1c). Sp1 also
strongly activated the GLUT4 promoter (∗∗P < 0.05, untransfected
versus Sp1). The co-transfection experiment of SREBP-1c with
Sp1 suggested that Sp1 may play an additive role in the SREBP-
1c mediated activation of the GLUT4 promoter (#P < 0.001
SREBP-1c versus SREBP-1c + Sp1). Co-transfection of SREBP-
Figure 3 Identification of the SRE and binding of SREBP-1 in the human
GLUT4 promoter
EMSA was performed with recombinant SREBP-1 protein in 4 % (w/w) non-denaturing
polyacrylamide gel. Then, 50 000 cpm (0.1 pmole) of 32P-labelled GLUT4 promoter fragments
(−125/−79) containing putative SRE was incubated with 20–80 ng of recombinant SREBP-1
protein. The DNA–protein complexes are indicated by arrowheads. LDLR-SRE, SRE region on
the promoter of the known low-density lipoprotein receptor.
1c with the wild-type construct (pHGT4d-313) or mutants Ma,
Mb or Mab to 3T3-L1 preadipocytes (Figure 5C) showed that
the Sp1 mutant caused a decrease in SREBP-1c-driven GLUT4
promoter activation (∗P < 0.05, pHGT4d-313 versus Ma). The
SRE mutant, Mb, also showed a decrease in the SREBP-1c-
mediated GLUT4 promoter activation (∗∗P < 0.05, pHGT4d-313
versus Mb). Mutations at both sites (Mab) reduced the promoter
activity to the basal level (Mab versus pGLM).
SREBP-1c mediates GLUT4 gene expression in differentiated
3T3-L1 adipocytes
To confirm a direct role of SREBP-1c on GLUT4 expression,
we treated differentiated 3T3-L1 adipocytes with 100 nM insulin
and adenovirus containing GFP or ADDN. The endogenous
GLUT4 gene expression is increased 4-fold by insulin and ADDN
decreased GLUT4 mRNA levels in a dose-dependent manner, as
shown by RT-PCR (Figure 6A) and real-time PCR (Figure 6B).
The FAS promoter was used as a positive control for ADDN action
(Figure 6C, #P < 0.005, GFP versus 200 MOI ADDN) [38]. As a
negative control, mRNA levels of β-actin whose gene expression
is known to be unaffected by ADDN [39] was measured by RT-
PCR (Figure 6C). These data suggest that SREBP-1c acts as
a trans-acting factor upregulating GLUT4 gene transcription in
3T3-L1 adipocytes.
SREBP-1c binding to the putative GLUT4-SRE is increased by
refeeding and insulin treatment in vivo
Rats were fasted for 48 h and refed ad libitum to observe the effect
of insulin on SREBP-1 binding to the putative SRE in the GLUT4
promoter. After 16 h, chromosomal DNA from adipose tissue was
cross-linked by formaldehyde and an antibody specific to SREBP-
1 was used to precipitate the chromatin fragment. We amplified
a specific region of the GLUT4 promoter (−254 bp/−30 bp)
by PCR (Figure 7A). The binding of SREBP-1 to the GLUT4
promoter was increased by refeeding (Figure 7B), suggesting that
the increased concentration of plasma insulin elicited by refeeding
c© 2006 Biochemical Society
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Figure 4 Binding of Sp1 and SREBP-1 to the GLUT4 promoter
(A) Schematic diagram of wild and mutated probes used in EMSA. The preparation of the site specific mutations are described in the Experimental section. (B–D) Direct and specific binding of the
recombinant Sp1 zinc-finger (ZF) (80 ng) and SREBP-1 (200 ng) to each of the putative binding sites in the human GLUT4 promoter. The EMSA was performed using 32P-labelled GLUT4 promoter
oligonucleotides, Sp1 and SREBP-1. SS, supershift.
might have increased the binding of SREBP-1 to the GLUT4-
SRE in the epididymal WAT. To confirm this effect of insulin
on the SREBP-1c binding to the GLUT4-SRE, we administered
insulin to STZ-induced diabetic rats and performed in vivo ChIP
assays (Figure 7C). As shown, the binding of SREBP-1c to the
SRE is restored by insulin treatment, suggesting that the insulin–
SREBP-1c pathway plays a role in the activation of GLUT4 gene
expression.
DISCUSSION
In T2DM or obesity, the amount of total GLUT4, as well as
insulin-mediated recruitment of GLUT4 from intracellular vesi-
cles to the plasma membrane, is reduced [40,41]. Although
adipose tissue accounts for only a small fraction of glucose dis-
posal [42], adipose specific knockout mice of the GLUT4 gene
display insulin resistance and glucose intolerance [43], suggesting
that the adipose tissue GLUT4 might play a critical role in the
glucose homoeostasis in vivo. This observation is further sup-
ported by the finding that overexpression of GLUT4 in the adipose
tissue improves glucose disposal and insulin sensitivity in vivo
[44]. The expression of GLUT4 is reduced in rodent models
of diabetes [45,46] and in the adipose tissues of obese and
T2DM subjects [16,17], indicating that GLUT4 in the adipose
tissue is linked to insulin resistance. Accordingly, understanding
mechanisms involved in the regulation of GLUT4 gene expression
might be critical in enhancing insulin sensitivity and reducing the
hyperglycaemia in T2DM. Despite the significant role of GLUT4
in glucose metabolism, the molecular mechanisms underlying the
transcriptional regulation of GLUT4 are poorly understood.
SREBP-1c is involved in the effect of insulin on the tran-
scription of genes involved in lipid and carbohydrate metabolism
[38,47,48]. Notably, SREBP-1c expression is decreased in the
liver during fasting and is increased by refeeding [49,50]. Thus,
it is tempting to speculate that the insulin–SREBP-1c pathway
in the adipocytes is involved in the up-regulation of GLUT4
gene expression. However, recent work using FIRKO (fat-specific
insulin receptor knock-out) mice showed that these mice display
a marked reduction in adipogenic transcription factors like
CCAAT/enhancer binding protein-α and SREBP-1c [51]. In this
animal model, reduction in GLUT1 but not in GLUT4 protein
levels was observed suggesting that GLUT1, rather than GLUT4,
expression is insulin-responsive. These results argue against the
current concept that GLUT4 is a direct target gene of insulin and
instead suggest that insulin regulates GLUT4 gene expression
through an indirect mechanism. Therefore it is likely that GLUT4
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Figure 5 The functional relationship between Sp1 and SREBP-1 in the
GLUT4 promoter
(A) The sequences of wild-type and the mutated construct of putative Sp1 and SREBP-1c
binding sites. The mutated bases are represented by bold characters. (B) The effect of the
SREBP-1c and Sp1 on human GLUT4 promoter activity. SREBP-1c or Sp1 expression vector was
transfected to 3T3-L1 preadipocytes. The luciferase activities were represented as fold changes
compared with the control group. *P < 0.001, untransfected versus SREBP-1c; **P < 0.05,
untransfected versus Sp1; #P < 0.001, SREBP-1c versus SREBP-1c + Sp1. (C) GLUT4–
luciferase constructs containing mutations in the Sp1 or SREBP-1c were generated as described
in the Experimental section. 3T3-L1 preadipocytes were co-transfected with each promoter
fragment linked to luciferase with or without SREBP-1c expression vectors. Ma, promoter re-
porter of mutated Sp1 sequence. Mb, promoter reporter of mutated SRE sequence. Mab,
promoter reporter of double mutated Sp1 and SRE sequences. Values are the means +− S.D.
of three independent experiments performed in triplicate. *P < 0.05, pHGT4d-313 versus Ma,
**P < 0.05, pHGT4d-313 versus Mb.
is regulated by the hormonal/metabolic milieu that develops as a
result of insulin deficiency.
In the present study, we observed that a fasting/refeeding
protocol caused an increase in SREBP-1c levels (Figure 1A)
and insulin administration to STZ-diabetic rats induced GLUT4
mRNA expression in epididymal WAT (Figure 1B). These results
are supported by Olson et al. [52] who showed the induction
by insulin in GLUT4-overexpressing transgenic mice of GLUT4
mRNA in WAT and brown adipose tissue (BAT). Refeeding
increased mRNA levels of SCD1 and FAS which are known target
genes of SREBP-1c (Figure 1C). However, there is a difference
in the induction time point between SCD1 (6 h) and FAS mRNA
(12 h). This result does not match with the onset of SREBP-1
mRNA induction. Insulin activates SREBP-1 gene transcription
as well as the processing of the premature form to the mature
form [53], therefore it could be possible that a small portion
of the pre-existing premature SREBP-1 can be converted to the
Figure 6 SREBP-1c mediates GLUT4 gene expression in differentiated 3T3-
L1 adipocytes
3T3-L1 adipocytes were treated with insulin (100 nM) and ADDN or null virus (adeno-GFP) at
the indicated MOI for 16 h at 37◦C with serum-free media and replaced with media including
serum. Total RNA was extracted for the measurement of GLUT4 mRNA using (A) RT-PCR or
(B) real-time PCR. (C) The effect of ADDN on FAS gene expression. The mRNA level was
normalized to that of α-tubulin in real-time PCR. β-Actin gene expression measured by RT-PCR
was used as a negative control. M, DNA marker. Values are the means +− S.D. of three independent
experiments performed in triplicate. #P < 0.005, GFP versus ADDN (200 MOI).
mature form, which in turn activates the target genes before a sub-
stantial amount of SREBP-1 is transcribed. Indeed, in the con-
dition where the premature form of SREBP-1c is increased, as
in adipocyte differentiation [54], insulin is shown to promote
the processing of SREBP-1c to the mature form resulting in the
activation of SREBP-1c target genes. During the refeeding period,
the mature form of SREBP-1 present in the nuclear fraction of
WAT, was increased after 6 h (Figure 1D), suggesting that insulin
may be involved in the processing of SREBP-1. From this data,
it is assumed that the appearance of mature SREBP-1 protein
coincides with or precedes GLUT4 mRNA induction.
Endogenous GLUT4 gene expression was increased by exo-
genous SREBP-1c in the differentiated 3T3-L1 adipocytes (Fig-
ure 1E). These results indicate that SREBP-1c acts as a positive
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Figure 7 SREBP-1c binding to putative GLUT4-SRE is increased by
refeeding and insulin treatment in vivo
(A) Scheme of amplifying the GLUT4 promoter in the ChIP assay. The region between −280
to −55 was amplified. (B) For the ChIP assay, chromatin extracted from epididymal WAT was
precipitated by SREBP-1 antibody and GLUT4-SRE was amplified by PCR. The amount of chro-
mosomal DNA used for the precipitation reaction was normalized by input chromatin (1/100th
of chromosomal DNA used for precipitation). F, fasted; R, refed. (C) The effect of insulin on
the binding of SREBP-1 to the GLUT4 promoter in adipose tissue of STZ-induced rats. Insulin
depleted diabetic rats were prepared by STZ. For the insulin treatment group, 0.1 mM/kg of
insulin was administrated to STZ-induced diabetic rats. The ChIP assay is representative of three
independent experiments. Blood glucose levels for the animal groups are shown in the Table. F:
48 h fasted, R: refeeding rats, S: STZ, I: insulin.
trans-acting factor for the GLUT4 gene. Thus, it is speculated
that insulin upregulates GLUT4 gene transcription and SREBP-
1c functions as a mediator of insulin action in the WAT of rats.
In the differentiated 3T3-L1 adipocytes, insulin induced GLUT4
mRNA levels and transduction of ADDN to the insulin-treated
3T3-L1 adipocytes resulted in the decrease in GLUT4 mRNA
(Figures 6A and 6B), indicating that insulin-induced SREBP-1c
could activate GLUT4 gene expression.
An in vivo ChIP assay showed that the refeeding or insulin
treatment of STZ-diabetic rats increased the binding of SREBP-1c
to the putative SRE in the GLUT4 promoter (Figure 7). In addition,
we showed that the upregulation of GLUT4 gene expression in
these states is directly mediated by the binding of SREBP-1c
to a conserved sequence (−109/−100, TGGGGTGTG) in the
GLUT4 promoter. This study provides evidence that GLUT4 gene
up-regulation could occur directly by the action of SREBP-1c and
expands the current understanding of the transcriptional control
of GLUT4 gene expression.
How does one explain the observation that GLUT4 is up-
regulated by SREBP-1c, a gene whose expression is not insulin-
responsive? In fact, the transcriptional control of the SREBP-
1c gene has been shown to be influenced by the combinatorial
effects of insulin and nutritional alterations [55,56]. Thus, it is
possible that the upregulation of GLUT4 expression could be
induced not only by insulin-induced SREBP-1c but also by several
transcription factors that might up-regulate the SREBP-1c gene.
Indeed, the SREBP-1c gene is activated by the liver X receptor
in adipocytes [57,58]. These results suggest that the GLUT4
gene can be activated by SREBP-1c which itself can be up-
regulated either by the independent or indirect action of insulin.
Indeed, Matsuzaka et al. [59] showed that SREBP-1c regulation
is independent of insulin in a situation where carbohydrate sup-
ply is sufficient in the livers of STZ-treated mice. In addition,
we and others have reported that SREBP-1c gene expression was
increased by glucose [36,60]. Based on these observations, we
suggest that SREBP-1c can activate GLUT4 gene expression by
directly binding to the SRE in the GLUT4 promoter.
The current study provides evidence that up-regulation of the
GLUT4 gene can be mediated by the direct action of SREBP-
1c and adds to the current understanding of the transcriptional
control of GLUT4 expression. Further studies are needed to
identify additional molecules that govern the SREBP-1c-mediated
activation of the GLUT4 gene.
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